Endocrine disruptors in hormone-sensitive female cancers

Thanks to their molecular affinity with natural hormones, endocrine disruptors (EDs) can interfere with the endocrine system by ac-tivating or blocking the receptor signal transduction. According to the World Health Organization, EDs and potential EDs are mostly man-made, found in various materials such as pesticides, metals, personal care products, additives or contaminants in food, and the human exposure to EDs occurs via ingestion of food, dust and water, via inhalation of gases and particles in the air, and through the skin. In 2015, the Endocrine Society released its second scientific statement about the evidence that EDs have effects on female repro-duction, breast development and hormone-sensitive cancers in females, such as breast cancer, endometrial cancer, and ovarian cancer. Therefore, prevention campaigns to reduce the female exposure to EDs and, consequently, the death burden of hormone-sensitive female cancers are needed.

Endocrine disruptors (EDs); Hormone-sensitive cancers.

Colborn T., vom Saal F.S., Soto A.M.: “Developmental effects of en-docrine-disrupting chemicals in wildlife and humans”. Environ. Health Perspect., 1993, 101, 378.

[2] Roncati L., Piscioli F., Pusiol T.: “The endocrine disrupting chemi-cals as possible stillbirth contributors”. Am. J. Obstet. Gynecol., 2016, 215, 532.

[3] Roncati L., Piscioli F., Pusiol T.: “The endocrine disruptors among the environmental risk factors for stillbirth”. Sci. Total Environ., 2016, 563-564, 1086.

[4] Roncati L., Termopoli V., Pusiol T.: “Negative role of the environ-mental endocrine disruptors in the human neurodevelopment”. Front. Neurol., 2016, 7, 143.

[5] Calabrese E.J., Baldwin L.A.: “Toxicology rethinks its central be-lief”. Nature, 2003, 421, 691.

[6] Veurink M., Koster M., Berg L.T.: “The history of DES, lessons to be learned”. Pharm. World Sci., 2005, 27, 139.

[7] Roncati L., Manenti A., Pusiol T., Piscioli F., Barbolini G., Maiorana A.: “Testosterone aromatization to estradiol in course of ovarian functioning Brenner tumor associated with endometrial carcinoma and endometriosis (Roncati-Manenti triad)”. Int. J. Gynecol. Cancer, 2016, 26, 1461.

[8] Cesinaro A.M., Roncati L., Maiorana A.: “Estrogen receptor alpha overexpression in multinucleate cell angiohistiocytoma: new insights into the pathogenesis of a reactive process”. Am. J. Dermatopathol., 2010, 32, 655.

[9] World Health Organization: “Endocrine Disrupting Chemicals (EDCs)”. Available at: https://www.who.int/ceh/risks/cehemerging2/en/

[10] European Environmental Agency: “Air quality in Europe - 2018 re-port”. Available at: https://www.eea.europa.eu/publications/air-qual-ity-in-europe-2018

[11] Gore A.C., Chappell V.A., Fenton S.E., Flaws J.A., Nadal A., Prins G.S., et al.: “Executive summary to EDC-2: the Endocrine Society’s second scientific statement on endocrine-disrupting chemicals”. En-docr. Rev., 2015, 36, 593.

[12] Roncati L., Barbolini G., Piacentini F., Piscioli F., Pusiol T., Maio-rana A.: “Prognostic factors for breast cancer: an immunomorpho-logical update”. Pathol. Oncol. Res., 2016, 22, 449.

[13] Roncati L., Barbolini G., Gatti A.M., Pusiol T., Piscioli F., Maiorana A.: “The uncontrolled sialylation is related to chemoresistant metastatic breast cancer”. Pathol. Oncol. Res., 2016, 22, 869.

[14] Roncati L., Gatti A.M., Barbolini G., Piscioli F., Pusiol T., Maiorana A.: “In vivo uptake of rare earth metals by triple-negative breast can-cer cells”. Pathol. Oncol. Res., 2018, 24, 161.

[15] Roncati L., Barbolini G., Ghirardini G., Rivasi F.: “Mature solid ter-atoma of the fallopian tube mimicking metastasis of endometrial ade-nocarcinoma: a case report”. Int. J. Surg. Pathol., 2010, 18, 561.

[16] Siegel R.L., Miller K.D., Jemal A.: “Cancer statistics, 2018”. CA Cancer J. Clin., 2018, 68, 7.